Study identifier:NIS-GMY-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Diagnosis and Response to Treatment Using a Reliable Gerd Questionnaire-an In Clinical Practise Study
Gastroesophageal Reflux Disease
-
No
-
All
250
Observational
18 Years - 79 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|